Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation

Liver Transplantation

Volumn 11, Issue 1, 2005, Pages 68-75

  Yagi, Shintaro ^a   Iida, Taku ^a   Taniguchi, Kentaro ^a   Hori, Tomohide ^a   Hamada, Takashi ^a   Fujii, Koji ^a   Mizuno, Shugo ^a   Uemoto, Shinji ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; METHYLPREDNISOLONE; PREDNISOLONE; SCATTER FACTOR; TACROLIMUS; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT DYSFUNCTION; HUMAN; HYPERBILIRUBINEMIA; INTERNATIONAL NORMALIZED RATIO; LIVER GRAFT REJECTION; LIVER HYPERTROPHY; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVER WEIGHT; LIVING DONOR; MALE; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VOLUMETRY;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD PRESSURE; FEMALE; GRAFT SURVIVAL; HUMANS; HYPERTENSION, PORTAL; LIVER DISEASES; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PORTAL VEIN; RETROSPECTIVE STUDIES;

EID: 12344283910     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20317     Document Type: Article

References (37)

1. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999;67:321-327.
2. Sato Y, Koyama S, Tsukada K, Hatakeyama K. Acute portal hypertension reflecting shear stress as a trigger of liver regeneration following partial hepatectomy. Surg Today 1997;27:518-526.
3. Niiya T, Murakami M, Aoki T, Murai N, Shimizu Y, Kusano M. Immediate increase of portal pressure, reflecting sinusoidal shear stress, induced liver regeneration after partial hepatectomy. J Hepatobiliary Pancreat Surg 1999;6:275-280.
4. Kawai M, Naruse K, Komatsu S, Kobayashi S, Nagino M, Nimura Y, Sokabe M. Mechanical stress-dependent secretion of interleukin 6 by endothelial cells after portal vein embolization: clinical and experimental studies. J Hepatol 2002;37:240-246.
5. Boillot O, Delafosse B, Mechet I, Boucaud C, Pouyet M. Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet 2002;359:406-407.
6. Shimamura T, Taniguchi M, Jin MB, Suzuki T, Matsushita M, Furukawa H, Todo S. Excessive portal venous inflow as a cause of allograft dysfunction in small-for-size living donor liver transplantation. Transplant Proc 2001;33:1331.
7. Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation 2003;75:1313-1317.
8. Lo CM, Liu CL, Fan ST. Portal hyperperfusion injury as the cause of primary nonfunction in a small-for-size liver graft-successful treatment with splenic artery ligation. Liver Transpl 2003;9:626-628.
9. Troisi R, de Hemptinne B. Clinical relevance of adapting portal vein flow in living donor liver transplantation in adult patients. Liver Transpl 2003;9:S36-S41.
10. Troisi R, Cammu G, Militerno G, De Baerdemaeker L, Decruyenaere J, Hoste E, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg 2003;237:429-436.
11. Boillot O, Mechet I, Le Derf Y, Bernard P, Figueiredo P, Berger F, et al. Portomesenteric disconnection for small-for-size grafts in liver transplantation: preclinical studies in pigs. Liver Transpl 2003;9:S42-S46.
12. Koyama S, Sato Y, Hatakeyama K. The subcutaneous splenic transposition prevents liver injury induced by excessive portal pressure after massive hepatectomy. Hepatogastroenterology 2003;50:37-42.
13. Smyrniotis VE, Kostopanagiotou G, Theodoraki K, Gamaletsos E, Kondi-Pafiti A, Mystakidou K, Arkadopoulos N. Effect of mesocaval shunt on survival of small-for-size liver grafts: experimental study in pigs. Transplantation 2003;75:1737-1740.
14. Takada Y, Ueda M, Ishikawa Y, Fujimoto Y, Miyauchi H, Ogura Y, et al. End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl 2004;10: 807-810.
15. Tanaka K, Uemoto S, Tokunaga Y, Fujita S, Sano K, Nishizawa T, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg 1993;217:82-91.
16. Inomata Y, Uemoto S, Asonuma K, Egawa H. Right lobe graft in living donor liver transplantation. Transplantation 2000;69: 258-264.
17. Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995;21:1317-1321.
18. Wang HH, Lautt WW. Evidence of nitric oxide, a flow-dependent factor, being a trigger of liver regeneration in rats. Can J Physiol Pharmacol 1998;76:1072-1079.
19. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003;299:890-893.
20. Matsumoto K, Tajima H, Okazaki H, Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids. J Biol Chem 1992;267:24917-24920.
21. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991;13:1-5.
22. Arakaki N, Kawakami S, Nakamura O, Ohnishi T, Miyazaki H, Ishii T, et al. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology 1995;22:1728-1734.
23. Tsubouchi H, Kawakami S, Hirono S, Miyazaki H, Kimoto M, Arima T, et al. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor. Lancet 1992; 340:307.
24. Miki C, Iriyama K, Strain A, Harrison JD, Hirono S, Gunson BK, et al. Clinical significance of serum hepatocyte growth factor in orthotopic liver transplantation. Surgery 1996;119:505-510.
25. Ninomiya M, Harada N, Shiotani S, Hiroshige S, Minagawa R, Soejima Y, et al. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation. Transpl Int 2003; 16:814-819.
26. Appasamy R, Tanabe M, Murase N, Zarnegar R, Venkataramanan R, Van Thiel DH, Michalopoulos GK. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest 1993;68:270-276.
27. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-848.
28. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845.
29. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-220.
30. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab 1994; 79:316-322.
31. Monacci WT, Merrill MJ, Oldfield EH. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993;264:C995-C1002.
32. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001;49:121-130.
33. Granot E, Boros P, Miller CM. Differential effect of hepatocyte growth factor and tumor growth factor-beta on early release of vascular endothelial growth factor from HepG2 cells: possible implications in post-transplant liver regeneration. Transplant Proc 2001;33:2926-2928.
34. Akiyoshi F, Sata M, Suzuki H, Uchimura Y, Mitsuyama K, Matsuo K, Tanikawa K. Serum vascular endothelial growth factor levels in various liver diseases. Dig Dis Sci 1998;43:41-45.
35. Scharte M, Han X, Bertges DJ, Fink MP, Delude RL. Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am J Physiol Gastrointest Liver Physiol 2003;284:G373-G384.
36. Tsugawa K, Hashizume M, Tomikawa M, Migou S, Kawanaka H, Shiraishi S, et al. Immunohistochemical localization of vascular endothelial growth factor in the rat portal hypertensive gastropathy. J Gastroenterol Hepatol 2001;16:429-437.
37. Assy N, Paizi M, Gaitini D, Baruch Y, Spira G. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol 1999;5:296-300.